After 150,000 articles and 17 million genome sequences, what has science taught us about SARS-CoV-2? Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The virologist had recently started an independent group at the University of Tokyo and was trying to carve out a niche in the crowded field of HIV research. “I thought, ‘What can I do for the next 20 or 30 years?’”
He found an answer in SARS-CoV-2, the virus responsible for the COVID-19 pandemic, that was rapidly spreading around the world. In March 2020, as rumours swirled that Tokyo might face a lockdown that would stop research activities, Sato and five students decamped to a former adviser’s laboratory in Kyoto. There, they began studying a viral protein that SARS-CoV-2 uses to quell the body’s earliest immune responses. Sato soon established a consortium of researchers that would go on to publish at least 50 studies on the virus.
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.